XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.81

-4.2%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StockDoc who wrote (14094)	7/11/2000 11:08:55 PM
From: Bluegreen	of 17367

Doc, remember that ANY gram neg infection requiring hospitalization is a bad disease. In Meningo. I think RAPID AND EFFECTIVE killing is key. Maybe less chance of gram neg bug progeny raising LPS levels. And I think it is also key in preventing sepsis in any other gram neg infection. With BPI added to conventional antibiotics IMMEDIATELY IF approved may just be routine therapy in any hospitalized case of gram neg infection. Which brings us back to SIGNIFICANT decrease in bacteremia in just 2 hours in the Baboon study. Cost of BPI treatment is non issue........if just ONE person dies from gram neg infection when BPI was available.....well, a lawyer would show you very quickly the cost of NOT using BPI.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next